Nanobiotechnology and its Application in Vaccine Delivery

References (85)

1. 1 Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review [DOI]
2. 2 Diffusion of univalent ions across the lamellae of swollen phospholipids [DOI]
3. 3 Nanoparticles in Medicine: Therapeutic Applications and Developments [DOI]
4. 4 Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. [DOI]
5. 5 Drug delivery systems: An updated review [DOI]
6. 6 Virus-like particles in vaccine development [DOI]
7. 7 Nanotechnology: convergence with modern biology and medicine [DOI]
8. 8 Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines [DOI]
9. 9 Virus-like particles: Passport to immune recognition [DOI]
10. 10 Surface-Engineered Magnetic Nanoparticle Platforms for Cancer Imaging and Therapy [DOI]
11. 11 Vaccine delivery using nanoparticles [DOI]
12. 12 Construction and Characterization of Virus-Like Particles: A Review [DOI]
13. 13 Biomimetics—using nature to inspire human innovation [DOI]
14. 14 Nanosystems in Drug Targeting: Opportunities and Challenges [DOI]
15. 15 Prevention of cervical cancer through papillomavirus vaccination [DOI]
16. 16 Polyanhydrides: an overview [DOI]
17. 17 Self-assembling protein nanoparticles in the design of vaccines [DOI]
18. 18 Nanomedicine and drug delivery: a mini review [DOI]
19. 19 Liposomes : a practical approach
20. 20 Targeted Drug Delivery in Cancer Therapy [DOI]
21. 21 Vaccine adjuvants: Current challenges and future approaches [DOI]
22. 22 Prospects and applications of nanobiotechnology: a medical perspective [DOI]
23. 23 Large-scale production and purification of VLP-based vaccines [DOI]
24. 24 Drug delivery vehicles on a nano-engineering perspective [DOI]
25. 25 Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines [DOI]
26. 26 The role of nanobiotechnology in drug discovery [DOI]
27. 27 Combinatorial Drug Conjugation Enables Nanoparticle Dual‐Drug Delivery [DOI]
28. 28 Lipid- and Polymer-Based Nanostructures for Cancer Theranostics [DOI]
29. 29 Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different Routes [DOI]
30. 30 Chemical Modification of Viruses and Virus-Like Particles [DOI]
31. 31 Virus-like particles as vaccine. [DOI]
32. 32 Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles [DOI]
33. 33 Liposomal adjuvants for human vaccines [DOI]
34. 34 Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses [DOI]
35. 35 Particles associated with Australia Antigen in the Sera of Patients with Leukaemia, Down's Syndrome and Hepatitis [DOI]
36. 36 Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy [DOI]
37. 37 Nanoparticles as synthetic vaccines [DOI]
38. 38 Virus-like particles: potential veterinary vaccine immunogens [DOI]
39. 39 Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres [DOI]
40. 40 Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice [DOI]
41. 41 Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept [DOI]
42. 42 Human immunodeficiency virus-like particles activate multiple types of immune cells [DOI]
43. 43 Formulating Poly(Lactide-Co-Glycolide) Particles for Plasmid DNA Delivery [DOI]
44. 44 An Overview on the Field of Micro- and Nanotechnologies for Synthetic Peptide-Based Vaccines [DOI]
45. 45 Biodegradable Microspheres for Parenteral Delivery [DOI]
46. 46 A Polymer/Oil Based Nanovaccine as a Single-Dose Immunization Approach [DOI]
47. 47 The use of hybrid virus‐like particles to enhance the immunogenicity of a broadly protective HPV vaccine [DOI]
48. 48 Nanoparticles in Vaccine Development
49. 49 Designing improved poly lactic-co-glycolic acid microspheres for a malarial vaccine: incorporation of alginate and polyinosinic–polycytidilic acid [DOI]
50. 50 Induction of protective neutralizing antibody responses against botulinum neurotoxin serotype C using plasmid carried by PLGA nanoparticles [DOI]
51. 51 Nano based drug delivery systems: recent developments and future prospects [DOI]
52. 52 Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations [DOI]
53. 53 The History of Nanoscience and Nanotechnology: From Chemical–Physical Applications to Nanomedicine [DOI]
54. 54 Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers [DOI]
55. 55 Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination [DOI]
56. 56 Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics [DOI]
57. 57 Magnetic Nanoparticles in Cancer Theranostics [DOI]
58. 58 Biomimetic Nanotechnology toward Personalized Vaccines [DOI]
59. 59 Effect of Physico-Chemical Properties of Nanoparticles on Their Intracellular Uptake [DOI]
60. 60 Nanoparticle therapeutics: an emerging treatment modality for cancer [DOI]
61. 61 Nanoparticles and Vaccine Development [DOI]
62. 62 Recent Advances in Polyanhydride Based Biomaterials [DOI]
63. 63 Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date * [DOI]
64. 64 Nanomaterials for Protein Delivery in Anticancer Applications [DOI]
65. 65 Cationic liposomes as vaccine adjuvants [DOI]
66. 66 Virus-Like Particle (VLP) Vaccine Conferred Complete Protection against a Lethal Influenza Virus Challenge [DOI]
67. 67 Graphene materials as 2D non-viral gene transfer vector platforms [DOI]
68. 68 Exploiting virus-like particles as innovative vaccines against emerging viral infections [DOI]
69. 69 Recent Advances in the Use of Plant Virus-Like Particles as Vaccines [DOI]
70. 70 Integrated Process for Capture and Purification of Virus-Like Particles: Enhancing Process Performance by Cross-Flow Filtration [DOI]
71. 71 Polymeric Nanocapsules for Vaccine Delivery: Influence of the Polymeric Shell on the Interaction With the Immune System [DOI]
72. 72 Adeno-associated virus capsid protein expression in Escherichia coli and chemically defined capsid assembly [DOI]
73. 73 Nanovaccines formulation and applications-a review [DOI]
74. 74 Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica [DOI]
75. 75 Preparation of Drug Liposomes by Reverse-Phase Evaporation [DOI]
76. 76 Role of Nanobiotechnology in Drug Discovery, Development and Molecular Diagnostic [DOI]
77. 77 A Short History of Vaccination [DOI]
78. 78 DNA-Loaded Cationic Liposomes Efficiently Function as a Vaccine against Malarial Proteins [DOI]
79. 79 Liposomal adjuvant development for leishmaniasis vaccines [DOI]
80. 80 Intranasal administration of cationic liposomes enhanced granulocyte–macrophage colony-stimulating factor expression and this expression is dispensable for mucosal adjuvant activity [DOI]
81. 81 Potent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric Nanoparticles [DOI]
82. 82 Multifunctional Nanoparticles in Precise Cancer Treatment: Considerations in Design and Functionalization of Nanocarriers [DOI]
83. 83 National Nanotechnology Initiative: A Model for Advancing Revolutionary Technologies [DOI]
84. 84 Construction of Novel Vaccines on the Basis of Virus-Like Particles: Hepatitis B Virus Proteins as Vaccine Carriers [DOI]
85. 85 A Vaccine Kit for Prevention and Therapy of Alzheimer’s Disease in a Transgenic Mouse Model [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Aptamer Functionalized Liposomes for Cancer Treatment — shares topic coverage
• Overcoming Barriers: Controlled-Release Systems as Vectors, the Posterior Segment of the Eye Approach as a Model — shares topic coverage
• DSPC Liposomes Improve Transport of L-cysteine and Reduce Metabolic Activity — shares topic coverage
• An Overview of FDA Approved Liposome Formulations for Cancer Therapy — shares topic coverage
• Sunflower Lecithin-based Liposomal Formulations of Sesbania grandiflora and Acerola cherry Extracts: Enhancing Stability and Controlled Release — shares topic coverage